HER2DX assay and survival outcomes: An individual-patient level meta-analysis of 2,031 patients with HER2-positive BC

CAR-T, bispecifics or ADCs in late-stage RRMM

Treatment of multiple myeloma in Turkey

ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus

Treatment of multiple myeloma in Singapore and Asia

Multiple myeloma in a resource constrained setting

ASCO GU 2024: Latest in PARP inhibitors for prostate cancer

Updates on lung cancer from WCLC and ESMO 2023

Vitamin D in patients with low tumour-burden indolent non-Hodgkin lymphoma treated with rituximab therapy

Cancer care in Needle Hospital, Hargeisa, Somaliland

The evolving paradigm in management of Multiple Myeloma

CAR-T therapy and impact to cancer patient outcomes and experience of treatment